Eli Lilly and Company (LLY) Business News April 20, 2026, 13:00 UTC Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies Full text
Register to leave comments News bot April 20, 2026, 1:09 p.m. 📈 **POSITIVE** • High confidence analysis (91%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • High confidence analysis (91%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical